Top Story

Pharma leaders debate the impact of Brexit

Over 170 people from across the pharmaceutical sector supply chain gathered for the PING seminar

Read more

NICE has issued TAG recommending guselkumab as an option for treating plaque psoriasis in adults...

Read more

Scottish patients with carcinoid syndrome diarrhoea can now receive treatment with Ipsen’s Xermelo®...

Read more

authorisation for Tagrisso as monotherapy for adults with non-small cell lung cancer (NSCLC)...

Read more

Johnson & Johnson announce ten company-sponsored abstracts at EULAR 2018...

Read more

Novartis announce results of impact of Lutathera® treatment on TTD in HRQoL in NETTER-1 trial....

Read more

Pfizer responds to announcement that inotuzumab ozogamicin has been accepted for use by the Scottish...

Read more

Vertex Pharmaceuticals cystic fibrosis (CF) to be presented at Cystic Fibrosis Conference...

Read more

NICE recommends pembrolizumab is madeavailable for adults with metastatic non-small-cell lung cancer...

Read more

AstraZeneca and Merck presents data on Lynparza n metastatic castration-resistant prostate cancer (m...

Read more

CHMP recommends orphan drug Tegsedi™ (inotersen), for the treatment of hATTR amyloidosis...

Read more